Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy.
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
02 03 2022
02 03 2022
Historique:
received:
24
12
2020
accepted:
30
03
2021
entrez:
3
3
2022
pubmed:
4
3
2022
medline:
14
4
2022
Statut:
epublish
Résumé
Facioscapulohumeral muscular dystrophy (FSHD) is among the most prevalent muscular dystrophies and currently has no treatment. Clinical and genetic heterogeneity are the main challenges to a full comprehension of the physiopathological mechanism. Improving our knowledge of FSHD is crucial to the development of future therapeutic trials and standards of care. National FSHD registries have been set up to this end. The French National Registry of FSHD combines a clinical evaluation form (CEF) and a self-report questionnaire (SRQ), filled out by a physician with expertise in neuromuscular dystrophies and by the patient, respectively. Aside from favoring recruitment, our strategy was devised to improve data quality. Indeed, the pairwise comparison of data from 281 patients for 39 items allowed for evaluating data accuracy. Kappa or intra-class coefficient (ICC) values were calculated to determine the correlation between answers provided in both the CEF and SRQ. Patients and physicians agreed on a majority of questions common to the SRQ and CEF (24 out of 39). Demographic, diagnosis- and care-related questions were generally answered consistently by the patient and the medical practitioner (kappa or ICC values of most items in these groups were greater than 0.8). Muscle function-related items, i.e. FSHD-specific signs, showed an overall medium to poor correlation between data provided in the two forms; the distribution of agreements in this section was markedly spread out and ranged from poor to good. In particular, there was very little agreement regarding the assessment of facial motricity and the presence of a winged scapula. However, patients and physicians agreed very well on the Vignos and Brooke scores. The report of symptoms not specific to FSHD showed general poor consistency. Patient and physician answers are largely concordant when addressing quantitative and objective items. Consequently, we updated collection forms by relying more on patient-reported data where appropriate. We hope the revised forms will reduce data collection time while ensuring the same quality standard. With the advent of artificial intelligence and automated decision-making, high-quality and reliable data are critical to develop top-performing algorithms to improve diagnosis, care, and evaluate the efficiency of upcoming treatments.
Sections du résumé
BACKGROUND
Facioscapulohumeral muscular dystrophy (FSHD) is among the most prevalent muscular dystrophies and currently has no treatment. Clinical and genetic heterogeneity are the main challenges to a full comprehension of the physiopathological mechanism. Improving our knowledge of FSHD is crucial to the development of future therapeutic trials and standards of care. National FSHD registries have been set up to this end. The French National Registry of FSHD combines a clinical evaluation form (CEF) and a self-report questionnaire (SRQ), filled out by a physician with expertise in neuromuscular dystrophies and by the patient, respectively. Aside from favoring recruitment, our strategy was devised to improve data quality. Indeed, the pairwise comparison of data from 281 patients for 39 items allowed for evaluating data accuracy. Kappa or intra-class coefficient (ICC) values were calculated to determine the correlation between answers provided in both the CEF and SRQ.
RESULTS
Patients and physicians agreed on a majority of questions common to the SRQ and CEF (24 out of 39). Demographic, diagnosis- and care-related questions were generally answered consistently by the patient and the medical practitioner (kappa or ICC values of most items in these groups were greater than 0.8). Muscle function-related items, i.e. FSHD-specific signs, showed an overall medium to poor correlation between data provided in the two forms; the distribution of agreements in this section was markedly spread out and ranged from poor to good. In particular, there was very little agreement regarding the assessment of facial motricity and the presence of a winged scapula. However, patients and physicians agreed very well on the Vignos and Brooke scores. The report of symptoms not specific to FSHD showed general poor consistency.
CONCLUSIONS
Patient and physician answers are largely concordant when addressing quantitative and objective items. Consequently, we updated collection forms by relying more on patient-reported data where appropriate. We hope the revised forms will reduce data collection time while ensuring the same quality standard. With the advent of artificial intelligence and automated decision-making, high-quality and reliable data are critical to develop top-performing algorithms to improve diagnosis, care, and evaluate the efficiency of upcoming treatments.
Identifiants
pubmed: 35236385
doi: 10.1186/s13023-021-01793-6
pii: 10.1186/s13023-021-01793-6
pmc: PMC8890461
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
96Investigateurs
Blandine Acket
(B)
Jean-Christophe Antoine
(JC)
Shahram Attarian
(S)
Guillaume Bassez
(G)
Anne-Laure Bédat-Millet
(AL)
Anthony Béhin
(A)
Rémi Bellance
(R)
Michela Bisciglia
(M)
Véronique Bombart
(V)
Rosalie Boitet
(R)
Pascale Bonnet
(P)
Françoise Bouhour
(F)
Célia Boutte
(C)
Brigitte Chabrol
(B)
Jean-Baptiste Chanson
(JB)
Françoise Chapon
(F)
Ariane Choumert
(A)
Pauline Coignard
(P)
Jean-Yves Cornu
(JY)
Benoît Daubail
(B)
Elisa De La Cruz
(E)
Léa Declerck
(L)
Capucine Delattre
(C)
Florence Demurger
(F)
Véronique Dulieu
(V)
Aurélie Duruflé
(A)
Fanny Duval
(F)
Florence Esselin
(F)
Teresinha Evangelista
(T)
Bruno Eymard
(B)
Anthony Faivre
(A)
Léonard Féasson
(L)
Xavier Ferrer
(X)
François Feuvrier
(F)
Olivier Flabeau
(O)
Mélanie Fradin
(M)
Alain Furby
(A)
Jérémy Garcia
(J)
Hélène Gervais-Bernard
(H)
Teresa Gidaro
(T)
Karima Ghorab
(K)
Marc Jeanpierre
(M)
Hubert Journel
(H)
Arnaud Lacour
(A)
Pascal Laforêt
(P)
Emmeline Lagrange
(E)
Valérie Layet
(V)
Gérard Leclaire
(G)
Jean-Luc Le Guiet
(JL)
Gwenaël Le Guyader
(G)
François Leroy
(F)
France Leturcq
(F)
Nicolas Lévy
(N)
Sarah Léonard-Louis
(S)
Laurent Magy
(L)
Edoardo Malfatti
(E)
Marion Masingue
(M)
Gilles Mazaltarine
(G)
Dominique Ménard
(D)
Maud Michaud
(M)
Marie-Christine Minot-Myhié
(MC)
Marie-Doriane Morard
(MD)
Juliette Nectoux
(J)
Karine Nguyen
(K)
Julie Nicomette
(J)
Jean-Baptiste Noury
(JB)
Sybille Pellieux
(S)
Laetitia Percebois-Macadré
(L)
Yann Péréon
(Y)
Solange Perrin-Callot
(S)
Philippe Petiot
(P)
Sylviane Peudenier
(S)
Bénédicte Pontier
(B)
Florence Portet
(F)
Jean Pouget
(J)
Marguerite Preudhomme
(M)
Hélène Rauscent
(H)
Dimitri Renard
(D)
Audrey Riou
(A)
François Rivier
(F)
Emmanuelle Salort-Campana
(E)
Stéphane Schaeffer
(S)
Jean-Philippe Simon
(JP)
Aurélie Siri
(A)
Marco Spinazzi
(M)
Tanya Stokovic
(T)
Juliette Svahn
(J)
François Tabaraud
(F)
Frédéric Taithe
(F)
Céline Tard
(C)
Christel Thauvin
(C)
Philippe Thoumie
(P)
Claire-Lise Tournier-Gervason
(CL)
Christine Tranchant
(C)
Jon Andoni Urtizberea
(JA)
Christophe Vial
(C)
Michel Vidaud
(M)
Fabien Zagnoli
(F)
Informations de copyright
© 2022. The Author(s).
Références
Comput Biol Med. 2014 Aug;51:1-13
pubmed: 24857941
Neurology. 2014 Sep 16;83(12):1056-9
pubmed: 25122204
Curr Neurol Neurosci Rep. 2016 Jul;16(7):66
pubmed: 27215221
J Clin Neurosci. 2012 Dec;19(12):1749-50
pubmed: 22999565
Neurology. 2013 Mar 26;80(13):1247-50
pubmed: 23446679
Neuromuscul Disord. 2017 Aug;27(8):782-790
pubmed: 28625604
JAMA. 1963 Apr 13;184:89-96
pubmed: 13997180
Muscle Nerve. 1981 May-Jun;4(3):186-97
pubmed: 7017401
Neuromuscul Disord. 2010 Jul;20(7):471-5
pubmed: 20554202
J Clin Epidemiol. 1990;43(6):543-9
pubmed: 2348207
J Clin Epidemiol. 1990;43(6):551-8
pubmed: 2189948
Neurology. 2020 Mar 10;94(10):421-422
pubmed: 32029549
Neuromuscul Disord. 2001 Sep;11(6-7):525-9
pubmed: 11525880
Genes (Basel). 2019 Nov 27;10(12):
pubmed: 31783696
J Neurol. 2016 Jul;263(7):1401-8
pubmed: 27159994
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Neurol. 2021 Jan;268(1):356-366
pubmed: 32813049
Curr Opin Neurol. 2011 Oct;24(5):423-8
pubmed: 21734574
Neurology. 1991 Dec;41(12):1878-81
pubmed: 1745341
NPJ Digit Med. 2020 Mar 9;3:30
pubmed: 32195365
Neurology. 1998 Jun;50(6):1791-4
pubmed: 9633729
Neuromuscul Disord. 2016 Mar;26(3):221-6
pubmed: 26948710
Contemp Clin Trials. 2015 Jul;43:1-9
pubmed: 25896116
Neuromuscul Disord. 2008 Dec;18(12):997-1001
pubmed: 18948006
Handb Clin Neurol. 2018;148:541-548
pubmed: 29478599
Clin Genet. 2009 Jun;75(6):550-5
pubmed: 19320656
Neuromuscul Disord. 2013 Apr;23(4):298-305
pubmed: 23434070
Neurotherapeutics. 2018 Oct;15(4):863-871
pubmed: 30361930
J Med Genet. 1989 Dec;26(12):755-60
pubmed: 2614794
Neurology. 2019 May 7;92(19):e2273-e2285
pubmed: 30979860
Muscle Nerve. 2014 Apr;49(4):520-7
pubmed: 23873337
BMC Neurol. 2019 Sep 10;19(1):224
pubmed: 31506080
Nat Genet. 2012 Dec;44(12):1370-4
pubmed: 23143600
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Ann Neurol. 1999 Jun;45(6):751-7
pubmed: 10360767
Orphanet J Rare Dis. 2018 Dec 4;13(1):218
pubmed: 30514324
J Med Genet. 1991 Oct;28(10):655-64
pubmed: 1941962